Many clients like this option because it is simple, convenient, and needle-free
Evaluation: Body fat (DXA scanning) Lean mass Insulin sensitivity Energy expenditure What they found: The combination showed an additive effect on fat reduction vs monotherapy AOD-9604 partially protected lean mass during GLP-1-induced weight reduction Increased energy expenditure in combination (~3 % vs GLP-1 alone) No new safety signals Why it matters: It validates the concept of combination , the idea that AOD-9604 may not work on its own, but can add value in combination with incretin agonists
With contributions from weight management experts, this book provides an in-depth exploration of adult weight management
Keep a low threshold for dermatology referral if new skin eruptions appear after injections
Both medicines work on the GLP-1 receptor, and using them together can increase the risk of adverse effects, like nausea, vomiting, and diarrhea, without providing any proven additional weight-loss benefits
PMID 22462611